Skip to main content
Home » Life Science Innovation » Healthtech is not just about innovation but a healthy nation
Life Science Innovation 2026

Healthtech is not just about innovation but a healthy nation

Jonathan Evans

Director of Communications, ABHI

Healthtech is helping transform healthcare, supporting prevention, productivity and economic growth while ensuring innovation reaches patients faster.


Encompassing medical devices, diagnostics and digital health technologies, healthtech is crucial to translating discovery into practical solutions for patients, healthcare systems and the economy. It will be central to the NHS’s strategic shifts: treatment to prevention, hospital to community and analogue to digital.

Supporting prevention

The UK’s healthcare challenges are increasingly shaped by ageing populations, rising rates of chronic disease and growing pressure on healthcare resources.

Healthtech is contributing through advanced diagnostics, remote monitoring, wearable technologies and AI-enabled tools that support earlier detection, more personalised care and improved disease management. By identifying health issues sooner and empowering people, they can improve outcomes while reducing pressure on healthcare services.

Beyond introducing new technologies,
healthtech is about redesigning care around patients’ needs

Enabling new models of care

Delivering care closer to home relies on innovation. Technologies supporting virtual wards, community diagnostics and digitally enabled pathways are helping patients access care in more convenient settings while allowing healthcare professionals to work more effectively.

Beyond introducing new technologies, healthtech is about redesigning care around patients’ needs, improving productivity and ensuring healthcare services remain sustainable as demand grows. The UK has unique advantages: a world-class research base, a vibrant life sciences sector and a healthcare system capable of supporting large-scale innovation. By creating the right conditions for adoption and investment, we can strengthen global competitiveness while improving patient outcomes. The challenge isn’t simply generating innovation, but ensuring innovation reaches people and communities who stand to benefit most.

Next article